RIYADH | SAUDI ARABIA – Saudi Arabia will soon begin Phase III clinical trials on around 5,000 people for a COVID-19 vaccine develop by China’s CanSino Biologics Inc., a Saudi health ministry spokesman said on Sunday.
Last month, CanSino’s co-founder said the company was in talks with Russia, Brazil and Saudi Arabia to launch a Phase III trial of the vaccine candidate, Ad5-nCOV.
The vaccine uses a harmless cold virus known as adenovirus type-5 (Ad5) to carry genetic material from the coronavirus into the body.
Researchers said last month that CanSino’s vaccine, co-developed with China’s military research unit, appeared to be safe and induced immune response in most subjects.
Saudi Arabia plans to test the vaccine alongside a placebo on 5,000 volunteers and is currently preparing trials in the cities of Riyadh, Dammam and Mecca, Sauti state news agency SPA said on Saturday.
No COVID-19 vaccine has been approved for commercial use.
CanSino’s candidate became the first in China to move into human testing in March but other potential vaccines developed by Sinovac Biotech and a unit of China National Pharmaceutical Group (Sinopharm) have already been approved for Phase III trials overseas.
Saudi Arabia’s King Salman issued a royal order to promote a number of members of the Public Prosecution Office, Saudi Press Agency (SPA) reported on Saturday. Attorney General Sheikh Saud bin Abdullah Al – Mujib praised the issuance of the royal order, and said that it came within the framework of the king and crown … More King Salman Issues Royal Order To Promote Members Of Public Prosecution Office
Visitors to Dracula’s castle are more likely to find puncture marks in their arms than their necks this month, after medics set up a COVID-19 vaccination centre at the Transylvanian attraction. Doctors and nurses with fang sticker on their scrubs are offering free Pfizer shots to all – comers at 14th century Bran Castle, which … More Vlad The Vaccinator: Dracula’s Castle Lures Visitors With COVID – 19 Jabs
BMW AG expects returns for its automotive business to be resilient this year even as surging commodity prices pose a risk to earnings. Profitability for its main cardmaking operations probably will come in at the upper end of the 6% to 8% range BMW had forecast for the year, the Munich – based company said … More BMW Expects To Hit High End Of Margin Goal Despite Rising Costs